NSAID induced gastrointestinal complications: the ARAMIS perspective--1997. Arthritis, Rheumatism, and Aging Medical Information System
- PMID: 9596549
NSAID induced gastrointestinal complications: the ARAMIS perspective--1997. Arthritis, Rheumatism, and Aging Medical Information System
Abstract
Gastrointestinal (GI) complications related to nonsteroidal antiinflammatory drug (NSAID) therapy are the most prevalent category of adverse drug reactions. Patients with arthritis are among the most frequent users of NSAID and are therefore particularly at risk for these side effects. To evaluate the nature of NSAID related GI complications and to determine how their frequency can be reduced, a series of studies of such complications in patients with rheumatic disease has been carried out based on data from the Arthritis, Rheumatism, and Aging Medical Information System (ARAMIS). We review the literature and present findings from the ARAMIS studies. This report addresses whether GI side effects such as dyspepsia can serve as warning symptoms for serious GI complications and describes the risk factors for these life threatening complications. It also describes differences among NSAID with regard to their GI toxicity and describes a study that investigated whether H2-receptor antagonists and antacids affect the development of serious GI complications. In addition, ongoing research and topics to be addressed in future studies are described.
Similar articles
-
Epidemiology of NSAID induced gastrointestinal complications.J Rheumatol Suppl. 1999 Apr;56:18-24. J Rheumatol Suppl. 1999. PMID: 10225536 Review.
-
Gastrointestinal tract complications of nonsteroidal anti-inflammatory drug treatment in rheumatoid arthritis. A prospective observational cohort study.Arch Intern Med. 1996 Jul 22;156(14):1530-6. Arch Intern Med. 1996. PMID: 8687261
-
Identification of patients at risk for gastropathy associated with NSAID use.J Rheumatol Suppl. 1990 Feb;20:12-9. J Rheumatol Suppl. 1990. PMID: 2325051
-
The evolution of arthritis antiinflammatory care: where are we today?J Rheumatol Suppl. 1999 Apr;56:11-7. J Rheumatol Suppl. 1999. PMID: 10225535 Review.
-
Determinants and sequelae associated with utilization of acetaminophen versus traditional nonsteroidal antiinflammatory drugs in an elderly population.Arthritis Rheum. 2002 Nov;46(11):3046-54. doi: 10.1002/art.10604. Arthritis Rheum. 2002. PMID: 12428249
Cited by
-
Non-steroidal anti-inflammatory drugs and gastroprotection with proton pump inhibitors: a focus on ketoprofen/omeprazole.Clin Drug Investig. 2012 Apr 1;32(4):221-33. doi: 10.2165/11596670-000000000-00000. Clin Drug Investig. 2012. PMID: 22350497 Review.
-
Small intestinal injury in NSAID users suffering from rheumatoid arthritis or osteoarthritis.Rheumatol Int. 2016 Nov;36(11):1557-1561. doi: 10.1007/s00296-016-3552-x. Epub 2016 Aug 22. Rheumatol Int. 2016. PMID: 27549792 Free PMC article.
-
Non-Steroidal Anti-Inflammatory Drugs: An Overview of Cardiovascular Risks.Pharmaceuticals (Basel). 2010 Jul 7;3(7):2146-2162. doi: 10.3390/ph3072146. Pharmaceuticals (Basel). 2010. PMID: 27713346 Free PMC article. Review.
-
High prevalence of NSAID enteropathy as shown by a simple faecal test.Gut. 1999 Sep;45(3):362-6. doi: 10.1136/gut.45.3.362. Gut. 1999. PMID: 10446103 Free PMC article. Clinical Trial.
-
Incidence of spontaneous notifications of adverse reactions with aceclofenac, meloxicam, and rofecoxib during the first year after marketing in the United Kingdom.Ther Clin Risk Manag. 2007 Jun;3(2):225-30. doi: 10.2147/tcrm.2007.3.2.225. Ther Clin Risk Manag. 2007. PMID: 18360631 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical